Liraglutide to Improve corONary Haemodynamics During Exercise streSS
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
A single-centre double-blind placebo-controlled crossover randomised controlled trial to
determine the physiological basis of glucagon-like peptide-1 receptor activation on exercise
haemodynamics, as manifest through specific electrophysiological parameters measured by
serial exercise stress testing, in those patients with reversible myocardial ischaemia and
obstructive coronary artery disease confirmed by a baseline exercise test and coronary
angiography respectively.